Objective: To assess the impact of treatment of subclinical hypothyroidism (SCH) on short-term pregnancy outcomes.
Method: Data from 4526 consecutive women with singleton pregnancies who delivered between January 2015 and December 2017 were analyzed. SCH was defined as a thyroid-stimulating hormone (TSH) level between 2.